Is INSM stock a Buy, Sell, or Hold?

Based on our analysis, INSM is currently a WAIT with low confidence. 📊 MIXED SIGNALS: INSM shows conflicting indicators. Wait for confirmation before entering.

What is the fair value of INSM stock?

Our analysis estimates the fair value range for INSM to be between $101.46 and $123.73. The current price is $123.74.

What is the analyst price target for INSM?

The average Wall Street analyst price target for INSM is $200.05. This implies a potential upside of 61.7% from current levels.

INSM Stock Analysis: Buy, Sell, or Hold?

INSM - Insmed, Inc.

PHARMACEUTICAL PREPARATIONS

$123.74

-2.59 (-2.05%) ▼

5d: -5.61%

30d: +15.15%

90d: +7.02%

WAIT

LOW Confidence

Protect Your INSM Gains

Analysis Updated: Aug 14, 2026 12:00 AM ET

Earnings: Aug 06, 2026 0d

Smart Money Distribution

Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →

Signal fired Aug 7, 2026 at $131.10 · last confirmed Aug 14, 2026

Strength: 7.9/10

Get Alerted When INSM Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 MIXED SIGNALS: INSM shows conflicting indicators. Wait for confirmation before entering.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 10.0%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$28.74

Based on 7.0% avg growth

INTRINSIC VALUE TODAY

$17.85

Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: INSM is currently trading at $123.74, which is considered extended relative to its 30-day fair value range of $101.46 to $123.73. From a valuation perspective, the stock is trading at a discount (Forward PE: 150.8) compared to its historical average (281.4). Remarkably, the market is currently pricing in an annual earnings decline of 18.8% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, INSM is in a strong downtrend. Immediate support is located at $96.42, while resistance sits at $137.70.

Market Sentiment: INSM scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $200.05 (+61.7%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED

Historical Trading Range $101.46 - $123.73

Company Quality Score 29/100 (SELL)

Volume Confirmation HIGH

Confidence Score 28.6%

Protect Your Profits

Holding INSM? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BEARISH: Price extended above range
BEARISH: Weak technical setup (0/100)
BULLISH: High volume confirmation
BULLISH: Trading 61.7% below Wall St target ($200.05)
WARNING: Composite score 29/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $101.46 - $123.73

Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $96.42

Resistance Level $137.70

Current Trend Strong Downtrend

Technical data as of Aug 14, 2026

Fundamental Context

Forward P/E (Next Year Est.) 150.81

Wall Street Target $200.05 (+61.7%)

Revenue Growth (YoY) 296.1%

Profit Margin -76.9%

Valuation Discount vs History -18.8% cheaper

PE vs Historical 150.8 vs 281.4 CHEAP

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -18.8% (market-implied from PE analysis)

1-Year Target $111.37 (-10%)

2-Year Target $100.23 (-19%)

3-Year Target $90.21 (-27%)

3-Yr Target (if PE normalizes) (PE: 151→281) $168.32 (+36%)

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 150.8 to 281.4

Stabilization Target: $230.89 (+86.6%)

PE Expansion Potential: +86.6%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: August 16, 2026 2:26 AM ET
Data refreshes hourly during market hours. Next update: 3:26 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is INSM showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

William Lewis SELL 10699 shares 2026-04-16

William Lewis SELL 10699 shares 2026-04-06

Roger Adsett SELL 88060 shares 2026-04-01

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for INSM.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
BMRN Biomarin Pharmaceutical …	STRONG BUY 29 analysts	$88	37 SELL
AXSM Axsome Therapeutics Inc	STRONG BUY 19 analysts	$282	66 BUY
SRPT Sarepta Therapeutics Inc	STRONG BUY 26 analysts	$22	27 SELL
BBIO BridgeBio Pharma Inc	STRONG BUY 19 analysts	$106	50 HOLD
INCY Incyte Corporation	HOLD 27 analysts	$125	49 HOLD

BMRN Biomarin Pharmace…

37 SELL

AXSM Axsome Therapeuti…

66 BUY

SRPT Sarepta Therapeut…

27 SELL

BBIO BridgeBio Pharma …

50 HOLD

INCY Incyte Corporation

49 HOLD

Advanced INSM Option Strategies

Professional options setups generated by AI based on today's INSM price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for INSM

INSM Technical Chart INSM Price Prediction INSM Earnings Date INSM Investment Advisor INSM Fair Price Analyzer INSM Options Advisor INSM Options Chain INSM Options Analysis INSM Competitors

Compare INSM with Peers

INSM vs CYTK
Which one to buy?

INSM vs ALNY
Which one to buy?

INSM vs RARE
Which one to buy?

INSM vs PTCT
Which one to buy?

INSM vs HALO
Which one to buy?

INSM vs SMMT

INSM vs ROIV
Winner: ROIV

ABVC vs INSM

INSM vs ONC
Winner: ONC

ABCL vs INSM

INSM vs CYTK

CMCSA vs INSM

RPRX vs INSM
Winner: RPRX

INSM vs INCY

INO vs INSM
Winner: INSM

Create New Comparison View All Competitors

Tradestie